(1)
Majem, M.; Álvarez, R.; Ortega, A. L.; Ruiz de Alda, L.; Gordo, R.; García, J. F.; Ivanova-Markova, Y.; González-Domínguez, A.; Sánchez San Cristóbal, R.; Rojo, F. Cost-Benefit Analysis of ALK Diagnosis Vs. Non-Diagnosis in Patients With Advanced non–small Cell Lung Cancer in Spain. Grhta 2022, 9, 82-90.